| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

* and
Ehrhardt Proksch1,
Department of Dermatology,1 Institute for Infection Medicine, University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany2
Received 10 October 2007/ Returned for modification 6 November 2007/ Accepted 27 February 2008
Searching the database for mouse homologs of the antimicrobial peptide human beta-defensin-3 (hBD-3) revealed highest identity (69%) to mouse beta-defensin-14 (mBD-14). Recombinant mBD-14 exhibited broad-spectrum, nanomolar microbicidal activity. Treatment of keratinocytes with gamma interferon or transforming growth factor alpha increased mBD-14 gene expression. These data suggest that mBD-14 is the functional ortholog of hBD-3.
Published ahead of print on 10 March 2008.
J.H. and E.P. share senior authorship of this article.
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |